ABSTRACT (1959, 1960, 1961) 
Rändle (1963) . The principle of these methods is either precipitation of the soluble insulin-anti-insulin complex with a precipitating antiserum, or (1963) found that at lower concentrations of the precipitating antiserum, artificially elevated insulin values could be de¬ monstrated in human plasma. This was assumed to be due to a cross reaction between human /-globulin and the precipitating antiserum. Kuzuya Se Samols (1964) showed that a cross reaction was possible between rat y-globulin and anti-guinea-pig )'-globulin from rabbits. With an excess of the precipitating antiserum, the cross reaction did not influence the recovery of 181I insulin. To exclude a cross reaction, Hales 8c Rändle (1963) Thereafter, 1 ml of the above mixture without tubercle bacilli was injected 7 times at 7-14 days intervals. Blood was withdrawn by cardiac puncture. AGPS-R-II, III, IV were delivered from Statens Seruminstitut, Copenhagen. The last-mentioned antisera were obtained by immunization of rabbits with guinea-pig y-globulin preparations.
The antisera were stored at -20°C in 4 ml portions after dilution with 0.04 M phos¬ phate buffer, pu 7.4, containing 0.5% human albumin and 0.9% NaCl.
Human Albumin
Human albumin was obtained from Statens Seruminstitut, Copenhagen, as a gift for scientific research.
125I-and ml-Insulin 125I-and 131I-insulin were prepared by the Hunter Se Greenwood (1962) method as described by Brunfeldt (1965 Iodination with 125I was performed on 10 ßg pig insulin. The protein-bound radio¬ activity, when using 125I, was on an average higher than with 131I, viz. about 90 %. Thus the specific radioactivity of the iodinated insulin was approximately 60 mc/mg.
After Sephadex filtration, the protein-bound radioactivity was collected into 5 ml. This was followed by dilution 800 times with 0.04 M phosphate buffer, fa 7.4, con¬ taining 1 % human albumin and 0.9 % NaCl. The solution was pipetted off in portions of 8 ml in tubes stored at -20°C. Thus, the theoretical concentration was 62.5 µ units/ml. When using 2 mc 131I~dissolved in about 50 ßl at alkaline reaction, about half the activity was lost through binding to the ampoule and rubber cap. Iodination with 131I was done on 5 ßg pig insulin. 70-90% of the available radioactivity was bound to the insulin. Thus, the specific radioactivity of the iodinated insulin was approxi¬ mately 140-180 mc/mg. After Sephadex filtration the protein-bound radioactivity was collected into 5 ml. This volume was then diluted 400 times with 0.04 M phosphate buffer, pH 7.4, containing 1 % human albumin and 0.9 % NaCl and stored at +4°C. Thus, in this case too, the final concentration of insulin was theoretically 62.5 ß units/ml.
Immunoelectroph or esis
The agar gel was prepared by mixing equal parts of a 2 % agar solution (Difco) with Veronal buffer, ps 8.6, ionic strength 0.1. 1 ß\ undiluted plasma or serum was applied. Electrophoresis was performed at room temperature, about 22°C, for 90 min, 120 V constant. 100 ßl precipitating antiserum was pipetted off into the trough. This was then stored for 2 days at room temperature in a moist chamber and thereafter, rinsed with 0.9 % NaCl for 2 days at room temperature. Drying was carried out with filter paper and staining with amido black for 3 min. Excess colour was removed with ethanol-acetic-acid water (4.5 : 4.5 : 1.0).
Determination of Insulin
For determining immunologically demonstrable insulin (IDI) in plasma and serum Hales Se Rändle's (1963) pre-precipitation technique (method B) was used. AIS-GP, diluted 1/8000, was mixed with equal parts of AGPS-R-III diluted 1/50. 0.1 ml of this mixture was pipetted off into tubes (9 X 50 mm) containing a glass bead. After incubation at +4°C for [16] [17] [18] hours, 200 ßl pig insulin standard solution (0, 7.8, 15.6, 31.3, 62.5, 125, 250 , and 500 ß units/ml) or 200 ßl plasma or serum and 100 µ 125I-or mI-insulin solution were added. Following incubation for another 24 hours at + 4°C, the antibody-bound and the free 125I-or 131I-insulin were separated by filtration through an Oxoid filter. The radioactivity was measured in a well counter (Philips).
To determine the maximum proportion of the added 125I-and 131I-insulin that could be bound to insulin antibodies, tubes containing AIS-G 1/100 and undiluted AGPS-R were run on every experimental day.
The immunological reactive part of 125I-and 131I-insulin was made up 92-95 % and 85-90% respectively of the total activity. In calculating the results, this value was taken to be 100 %. SEM (duplicate determ.) was ± 0.8 % precipitated radioactivity (ordinate value) by counting 104 pulses.
In 
RESULTS

Immunoelectrophoretic Studies
Immunoelectrophoresis was carried out on AIS-GP and human plasma using 4 different AGPS-R preparations as precipitating sera (Fig. 1) 
Significance of AGPS-R Concentration in Recovering Labelled Insulin
Experiments using decreasing concentrations of the precipitating antiserum, performed without pre-precipitation (method A) showed that it was only with AGPS-R-III that a submaximal recovery was demonstrated at the higher con-centrations used (lower dilutions) (Fig. 2) . With pre-precipitation (method B) the experiments using AGPS-R-II, III, and IV showed definite maxima, par¬ ticularly marked for II The effect of plasma and serum from 2 normal subjects on the recovery of radioactive insulin was also investigated at decreasing AGPS-R concentrations. These experiments were carried out 7 days and 1 day respectively after with¬ drawing the blood samples which were stored at +4°C. The precipitating antiserum used for these experiments was AGPS-R-III (Fig. 3) with which immunoelectrophoresis showed a cross reaction with human plasma protein components, and AGPS-R-IV (Fig. 4) , with which such cross reaction was not demonstrable.
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The recovery on the addition of plasma and serum was compared with the recovery on the addition of 0.5 % human albumin dissolved in phosphate buffer, pa 7.4.
Using AGPS-R-III without pre-precipitation (method A) (Fig. 3) for plasma than for serum were found up to a dilution of AGPS-R-III ex¬ ceeding 1/256. The recovery on addition of a 0.5 % human albumin solution was higher than on addition of plasma or serum up to a dilution of AGPS-R-III exceeding 1/128. Thus, when using pre-precipitation, »negative« insulin values could not be obtained with the precipitating antiserum used, until the dilution exceeded 1/128.
The use of the precipitating antiserum AGPS-R-IV without pre-precipitation (method A) (Fig. 4) showed a somewhat higher recovery on addition of plasma than of serum. The plasma and serum used for these experiments was ob¬ tained, as already mentioned, from a normal subject different from the one in the AGPS-R-III experiments. The recovery on addition of 0.5 % albumin solution was found to be higher than on addition of plasma or serum, up to a dilution of AGPS-R-IV exceeding 1/128. With pre-precipitation (method B) (Fig. 4) there was a considerably higher recovery on addition of plasma than of serum up to a dilution of AGPS-R-IV of 1/1024. The recovery on addition of 0.5 % human albumin was found to be higher than on addition of plasma or serum up to a dilution of AGPS-R-IV of rather more than 1/128 and 1/512 respectively.
Determination of Insulin in Plasma and Serum
By simultaneous insulin determinations on plasma and serum by method (with pre-precipitation) and using optimal concentration of AIS-GP and AGPS-R, it was possible, in certain cases, to obtain identical values for freshly drawn plasma and serum (Fig. 5) . In other cases highly elevated insulin con¬ centrations were found in the serum as compared with plasma (Fig. 6) (Fig. 6) (Fig. 8) .
Determinations on the plasma used for the experiment illustrated in Fig. 7 showed, on dilution, a direct proportionality between the degree of dilution and the insulin concentrations found. On the other hand, this did not apply to the corresponding serum until a dilution exceeding 1/2 was used (Fig. 9) 
